Stroke and Thromboprophylaxis in the Era of COVID-19.
作者信息
Ma Alice, Kase Carlos S, Shoamanesh Ashkan, Abdalkader Mohamad, Pikula Aleksandra, Sathya Anvitha, Catanese Luciana, Ellis Alun T, Nguyen Thanh N
机构信息
Neurosurgery, Royal North Shore Hospital, Sydney, Australia.
Neurology, Emory University, Atlanta, Georgia, USA.
出版信息
J Stroke Cerebrovasc Dis. 2021 Jan;30(1):105392. doi: 10.1016/j.jstrokecerebrovasdis.2020.105392. Epub 2020 Oct 9.
Abstract
摘要
相似文献
1
Stroke and Thromboprophylaxis in the Era of COVID-19.
J Stroke Cerebrovasc Dis. 2021 Jan;30(1):105392. doi: 10.1016/j.jstrokecerebrovasdis.2020.105392. Epub 2020 Oct 9.
2
COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy.
Thromb Res. 2020 Dec;196:483-485. doi: 10.1016/j.thromres.2020.10.004. Epub 2020 Oct 15.
3
Can combined (mechanical and pharmacological) modalities prevent fatal VTE?
Int Angiol. 2011 Apr;30(2):115-22.
4
Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.
Semin Thromb Hemost. 2020 Oct;46(7):789-795. doi: 10.1055/s-0040-1714273. Epub 2020 Aug 20.
5
Intracranial Hemorrhage in Hospitalized SARS-CoV-2 Patients: A Case Series.
J Stroke Cerebrovasc Dis. 2021 Jan;30(1):105428. doi: 10.1016/j.jstrokecerebrovasdis.2020.105428. Epub 2020 Nov 2.
6
Antithrombotic treatment in atrial fibrillation.
Heart. 2007 Jan;93(1):39-44. doi: 10.1136/hrt.2006.099911. Epub 2006 Sep 4.
7
Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.
Thromb Haemost. 2008 Feb;99(2):295-304. doi: 10.1160/TH07-08-0508.
8
Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial.
Trials. 2016 Aug 3;17(1):390. doi: 10.1186/s13063-016-1520-0.
9
What is the optimum strategy for thromboembolic prophylaxis following extrapleural pneumonectomy in patients with malignant pleural mesothelioma?
Interact Cardiovasc Thorac Surg. 2012 Aug;15(2):201-3. doi: 10.1093/icvts/ivs158. Epub 2012 Apr 23.
10
COVID-19 and thrombosis: From bench to bedside.
Trends Cardiovasc Med. 2021 Apr;31(3):143-160. doi: 10.1016/j.tcm.2020.12.004. Epub 2020 Dec 16.
引用本文的文献
1
SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model.
Transl Stroke Res. 2024 Oct 2. doi: 10.1007/s12975-024-01301-5.
2
Comparison of Standard Versus Intermediate Prophylaxis Dose for Venous Thromboembolism Prophylaxis in Patients Hospitalized With COVID-19 Infection.
Hosp Pharm. 2024 Feb;59(1):94-101. doi: 10.1177/00185787231194997. Epub 2023 Aug 26.
3
COVID-19 Countermeasures in Acute Stroke.
J Neuroendovasc Ther. 2021;15(8):479-483. doi: 10.5797/jnet.sr.2021-0042. Epub 2021 Jul 3.
4
Venous thromboembolism among Medicare acute ischaemic stroke patients with and without COVID-19.
Stroke Vasc Neurol. 2023 Jun;8(3):259-262. doi: 10.1136/svn-2022-001814. Epub 2022 Nov 15.
5
Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events: A 1-Year Follow-up.
Neurology. 2023 Jan 24;100(4):e408-e421. doi: 10.1212/WNL.0000000000201426. Epub 2022 Oct 18.
6
Simultaneous Pulmonary Embolism and Carotid Thrombosis as a Presenting Manifestation of COVID-19.
Case Rep Neurol Med. 2022 Aug 23;2022:4933172. doi: 10.1155/2022/4933172. eCollection 2022.
7
Anticoagulation and Stroke.
Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):72-79. doi: 10.1590/0004-282X-ANP-2022-S132.
8
Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality.
J Stroke. 2022 May;24(2):256-265. doi: 10.5853/jos.2022.00752. Epub 2022 May 31.
9
Therapeutic Trends of Cerebrovascular Disease during the COVID-19 Pandemic and Future Perspectives.
J Stroke. 2022 May;24(2):179-188. doi: 10.5853/jos.2022.00843. Epub 2022 May 31.
10
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.
Sci Rep. 2022 May 4;12(1):7249. doi: 10.1038/s41598-022-11103-0.
本文引用的文献
1
Hemorrhagic stroke and anticoagulation in COVID-19.
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104984. doi: 10.1016/j.jstrokecerebrovasdis.2020.104984. Epub 2020 May 23.
2
COVID-19-associated Diffuse Leukoencephalopathy and Microhemorrhages.
Radiology. 2020 Oct;297(1):E223-E227. doi: 10.1148/radiol.2020202040. Epub 2020 May 21.
3
SARS-CoV-2 and Stroke in a New York Healthcare System.
Stroke. 2020 Jul;51(7):2002-2011. doi: 10.1161/STROKEAHA.120.030335. Epub 2020 May 20.
4
Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19.
Ann Neurol. 2020 Aug;88(2):211-214. doi: 10.1002/ana.25774. Epub 2020 Jun 3.
5
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.
J Thromb Thrombolysis. 2020 Aug;50(2):281-286. doi: 10.1007/s11239-020-02130-7.
6
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
7
Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
Platelets. 2020 Jul 3;31(5):674-679. doi: 10.1080/09537104.2020.1760230. Epub 2020 May 5.
8
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
9
Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology.
Stroke. 2020 Jun;51(6):1896-1901. doi: 10.1161/STROKEAHA.120.030100. Epub 2020 Apr 29.
10
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.
N Engl J Med. 2020 May 14;382(20):e60. doi: 10.1056/NEJMc2009787. Epub 2020 Apr 28.
Zotero 插件